Product Description
Meprobamate is used to treat anxiety disorders or for short-term relief of the symptoms of anxiety in adults and children 6 years of age and older. Meprobamate is in a class of medications called tranquilizers. It works by slowing activity in the brain to allow for relaxation. (Sourced from: https://medlineplus.gov/druginfo/meds/a682077.html)
Mechanisms of Action: GABA Agonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral,Intravenous,Intraocular
FDA Designation: None *
Approval Status: Approved
Approved Countries: Argentina | Brazil | Canada | Chile | Egypt | Ireland | Lebanon | Morocco | New Zealand | Pakistan | Portugal | South Africa | Taiwan | Thailand | Tunisia | United Kingdom | United States
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|